Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03444207
Other study ID # 1077/12; 753/13
Secondary ID
Status Completed
Phase N/A
First received February 13, 2018
Last updated February 18, 2018
Start date December 6, 2012
Est. completion date December 30, 2017

Study information

Verified date February 2018
Source Poznan University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to compare the effects of three months' endurance training and three months' endurance-strength training on inflammatory markers in women with abdominal obesity.


Description:

Study patients. Written informed consent was obtained from all subjects. The study meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996.

Study design. The study was designed as a prospective randomized trial. Subjects were randomly divided into two groups, A and B, using a randomization list. Both groups performed three month of physical training. Group A underwent endurance training, while group B performed endurance-strength training. Aside from the training, all subjects were instructed to maintain the physical activity and diet that they had been practicing so far. At baseline and after three months of physical training, blood samples for laboratory analyses were taken, anthropometric measurements were performed for both groups.

Intervention. The exercise program lasted three months, with three sessions per week. Women in both groups participated in a total of 36 training sessions. The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity. Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate. Both the endurance and endurance-strength training were comparable in exercise volume; the only difference was the nature of the effort.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date December 30, 2017
Est. primary completion date December 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- informed written consent;

- simple obesity;

- age from 18 to 65 years;

- body fat content, assessed by electrical bioimpedance, equal to or more than 33%;

- waist circumference more than 80 cm;

- stable body weight in the one month prior to the trial.

Exclusion Criteria:

- secondary form of excess body mass

- secondary form of arterial hypertension

- mean systolic blood pressure > 140 mmHg and/or mean diastolic blood pressure > 90 mmHg;

- diabetes;

- ischemic heart disease;

- stroke;

- heart failure;

- history of malignancy;

- clinically significant heart arrhythmias;

- a history of use of any dietary supplement;

- serious liver or kidney damage;

- abnormal thyroid gland function;

- clinically significant inflammation, connective tissue disease, or arthritis;

- nicotine, alcohol, or narcotic abuse;

- infection;

- pregnancy, childbirth, or lactation;

- any other condition that would make participation not in the best interest of the subject, or could prevent the efficacy of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Endurance training
The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity.
Endurance-strength training
Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate.

Locations

Country Name City State
Poland Department of Education and Obesity Treatment and Metabolic Disorders; Poznan University of Medical Sciences Poznan

Sponsors (1)

Lead Sponsor Collaborator
Poznan University of Medical Sciences

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary C-reactive protein (CRP) at baseline Serum concentration of C-reactive protein at baseline At baseline
Primary CRP after three months of physical training Serum concentration of C-reactive protein after three months of physical training after three months of physical training
Secondary tumor necrosis factor alpha (TNFa) at baseline Serum concentration of tumor necrosis factor alpha at baseline at baseline
Secondary TNFa after three months of physical training Serum concentration of tumor necrosis factor alpha after three months of physical training after three months of physical training
Secondary soluble receptor 2 of TNF alpha (sTNF R2) at baseline Serum concentration of soluble receptor 2 of TNF alpha at baseline At baseline
Secondary sTNF R2 after three months of physical training Serum concentration of soluble receptor 2 of TNF alpha after three months of physical training after three months of physical training
Secondary interleukin 6 (IL-6) at baseline Serum concentration of interleukin 6 at baseline At baseline
Secondary IL-6 after three months of physical training Serum concentration of interleukin 6 after three months of physical training after three months of physical training
Secondary interleukin 1 (IL-1) at baseline Serum concentration of interleukin 1 at baseline At baseline
Secondary IL-1 after three months of physical training Serum concentration of interleukin 1 after three months of physical training after three months of physical training
Secondary visfatin at baseline Serum concentration of visfatin at baseline At baseline
Secondary visfatin after three months of physical training Serum concentration of visfatin after three months of physical training after three months of physical training
Secondary Body mass at baseline Body mass at baseline At baseline
Secondary Body mass after three months of physical training Body mass after three months of physical training after three months of physical training
Secondary Body height at baseline Body height at baseline At baseline
Secondary Body height after three months of physical training Body height after three months of physical training after three months of physical training
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2